GLD patients who received HSCT showed an improvement in axonal integrity and myelin thickness, as well as a reduction of phagocytic CD68+ microglia, fewer multinucleated phagocyte clumps (also termed globoid cells) and reduced substrate accumulation in macrophages (Weinstock et al., 2020). The gene discussed is CD68; the disease is Krabbe disease.